Consult
Log In
Menu
Consult
Log in

by Josh Forsythe, on July 19, 2016

ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to clinical labs. Under the terms of the agreement, PierianDx will integrate Archer ® targeted NGS testing pipelines into the PierianDX Clinical mGenomicist Workspace™ (CGW), the leading cloud-based platform that provides clinical labs more streamlined and accurate NGS data analysis, interpretation, and reporting.

Read Story
Topics:News